Contact this trialFirst, we need to learn more about you.
Standard Care for Prostate Cancer
Recruiting4 awardsPhase 3
Montréal, Quebec
This trial is designed to compare the standard of care for prostate cancer patients undergoing radiation therapy (RT) with preventive treatment with the drug Rapaflo. The trial will recruit 188 patients across Quebec who will be randomized into two arms: those receiving Rapaflo at the start of RT, and those receiving it if/when symptoms appear.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service